Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT) – phase I/II trial: study protocol

BACKGROUND: The implementation of combined radiochemotherapy (RCHT) with temozolomide (TMZ) has lead to a significant increase in overall survival times in patients with Glioblastoma multiforme (GBM), however, outcome still remains unsatisfactory. The majority of GBMs show an overexpression and/or a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Combs, Stephanie E, Heeger, Steffen, Haselmann, Renate, Edler, Lutz, Debus, Jürgen, Schulz-Ertner, Daniela
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2006
Assuntos:
Study Protocol
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1524973/
https://ncbi.nlm.nih.gov/pubmed/16709245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-6-133
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares